Filing Details

Accession Number:
0001516551-24-000119
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-20 08:23:53
Reporting Period:
2024-11-15
Accepted Time:
2024-11-20 08:23:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516551 Skye Bioscience Inc. SKYE Pharmaceutical Preparations (2834) 450692882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2013809 Tu Tuan Diep 11250 El Camino Real
Suite 100
San Diego CA 92130
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-11-15 85 $5.55 101,748 No 4 S Direct
Common Stock Disposition 2024-11-18 19,489 $4.99 82,259 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
  2. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.